Cargando…
Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years
INTRODUCTION: Parathyroid carcinoma (PC) is an uncommon clinical entity. Identification and appropriate treatment of PC remains a challenge. In this study, we explore clinico-radiological features suggestive of PC, the utility of Castleman's histopathological criteria for the diagnosis of PC an...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333759/ https://www.ncbi.nlm.nih.gov/pubmed/32699779 http://dx.doi.org/10.4103/ijem.IJEM_588_19 |
_version_ | 1783553812318912512 |
---|---|
author | Nayyar, Supreet Singh Thiagarajan, Shivakumar Chaukar, Devendra Laskar, Sarbani Ghosh Patil, Asawari Mahajan, Abhishek Shah, Snehal |
author_facet | Nayyar, Supreet Singh Thiagarajan, Shivakumar Chaukar, Devendra Laskar, Sarbani Ghosh Patil, Asawari Mahajan, Abhishek Shah, Snehal |
author_sort | Nayyar, Supreet Singh |
collection | PubMed |
description | INTRODUCTION: Parathyroid carcinoma (PC) is an uncommon clinical entity. Identification and appropriate treatment of PC remains a challenge. In this study, we explore clinico-radiological features suggestive of PC, the utility of Castleman's histopathological criteria for the diagnosis of PC and discuss the MD-Anderson prognostic stratification system for PC. METHODS: Retrospective analysis (case series) of patients who were treated at our tertiary oncology institution between January 2009 and December 2018 with an eventual diagnosis of PC. RESULTS: The study group comprised 15 patients. The most common presentation was related to the musculoskeletal system (n = 9, 60%). In one of the cases, ultrasound features were recorded to be suspicious of PC. The highest histopathological correlation with PC was found with capsular and vascular invasion (n = 12, 80%). The primary tumor was found in inferior parathyroid glands in most cases (n = 12, 80%). The average tumor size was 2.47 cm. Six patients (40%) received adjuvant radiotherapy (RT). Three patients (20%) developed recurrence, all having distant metastasis. Overall survival (OS) at 3 years was 92.31% and disease-free survival (DFS) of 76.61%. CONCLUSION: The presence of certain features on ultrasonography might suggest PC preoperatively. Among Castleman's criteria, capsular invasion and vascular invasion had a maximum association with PC in our series. At present, there is no evidence to routinely give adjuvant RT to all patients with PC. |
format | Online Article Text |
id | pubmed-7333759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-73337592020-07-21 Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years Nayyar, Supreet Singh Thiagarajan, Shivakumar Chaukar, Devendra Laskar, Sarbani Ghosh Patil, Asawari Mahajan, Abhishek Shah, Snehal Indian J Endocrinol Metab Original Article INTRODUCTION: Parathyroid carcinoma (PC) is an uncommon clinical entity. Identification and appropriate treatment of PC remains a challenge. In this study, we explore clinico-radiological features suggestive of PC, the utility of Castleman's histopathological criteria for the diagnosis of PC and discuss the MD-Anderson prognostic stratification system for PC. METHODS: Retrospective analysis (case series) of patients who were treated at our tertiary oncology institution between January 2009 and December 2018 with an eventual diagnosis of PC. RESULTS: The study group comprised 15 patients. The most common presentation was related to the musculoskeletal system (n = 9, 60%). In one of the cases, ultrasound features were recorded to be suspicious of PC. The highest histopathological correlation with PC was found with capsular and vascular invasion (n = 12, 80%). The primary tumor was found in inferior parathyroid glands in most cases (n = 12, 80%). The average tumor size was 2.47 cm. Six patients (40%) received adjuvant radiotherapy (RT). Three patients (20%) developed recurrence, all having distant metastasis. Overall survival (OS) at 3 years was 92.31% and disease-free survival (DFS) of 76.61%. CONCLUSION: The presence of certain features on ultrasonography might suggest PC preoperatively. Among Castleman's criteria, capsular invasion and vascular invasion had a maximum association with PC in our series. At present, there is no evidence to routinely give adjuvant RT to all patients with PC. Wolters Kluwer - Medknow 2020 2020-04-30 /pmc/articles/PMC7333759/ /pubmed/32699779 http://dx.doi.org/10.4103/ijem.IJEM_588_19 Text en Copyright: © 2020 Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Nayyar, Supreet Singh Thiagarajan, Shivakumar Chaukar, Devendra Laskar, Sarbani Ghosh Patil, Asawari Mahajan, Abhishek Shah, Snehal Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years |
title | Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years |
title_full | Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years |
title_fullStr | Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years |
title_full_unstemmed | Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years |
title_short | Parathyroid Carcinoma—An Experience of the Enigma Over 10 Years |
title_sort | parathyroid carcinoma—an experience of the enigma over 10 years |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333759/ https://www.ncbi.nlm.nih.gov/pubmed/32699779 http://dx.doi.org/10.4103/ijem.IJEM_588_19 |
work_keys_str_mv | AT nayyarsupreetsingh parathyroidcarcinomaanexperienceoftheenigmaover10years AT thiagarajanshivakumar parathyroidcarcinomaanexperienceoftheenigmaover10years AT chaukardevendra parathyroidcarcinomaanexperienceoftheenigmaover10years AT laskarsarbanighosh parathyroidcarcinomaanexperienceoftheenigmaover10years AT patilasawari parathyroidcarcinomaanexperienceoftheenigmaover10years AT mahajanabhishek parathyroidcarcinomaanexperienceoftheenigmaover10years AT shahsnehal parathyroidcarcinomaanexperienceoftheenigmaover10years |